B-cell-activating factor and autoimmune myasthenia gravis

Autoimmune Diseases

Volumn 1, Issue 1, 2011, Pages

  Ragheb, Samia ^a   Lisak, Robert P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ATACICEPT; AUTOIMMUNE REGULATOR PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; BELIMUMAB; BETA INTERFERON; CXCL13 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 17; NOTCH RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; HOMEOSTASIS; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; LYMPHOID HYPERPLASIA; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMUS HYPERPLASIA;

EID: 84871269283     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.4061/2011/939520     Document Type: Review

References (170)

1. Patrick J., Lindstrom J., Autoimmune response to acetylcholine receptor Science 1973 180 4088 871 872
2. Ragheb S., Lisak R. P., Lisak R. P., The immunopathogenesis of acquired (autoimmune) myasthenia gravis Handbook of Myasthenia Gravis and Myasthenic Syndromes 1994 New York, NY, USA Dekker 239 276
3. Pal J., Rozsa C., Komoly S., Illes Z., Clinical and biological heterogeneity of autoimmune myasthenia gravis Journal of Neuroimmunology 2011 231 1-2 43 54
4. Appel S. H., Almon R. R., Levy N., Acetylcholine receptor antibodies in myasthenia gravis The New England Journal of Medicine 1975 293 15 760 761
5. Lennon V. A., Jones G., Howard F. M., Elveback L., Autoantibodies to acetylcholine receptors in myasthenia gravis The New England Journal of Medicine 1983 308 7 402 403
6. Drachman D. B., De Silva S., Ramsay D., Pestronk A., Humoral pathogenesis of myasthenia gravis Annals of the New York Academy of Sciences 1987 505 90 105
7. Evoli A., Tonali P. A., Padua L., Lo Monaco M., Scuderi F., Batocchi A. P., Marino M., Bartoccioni E., Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis Brain 2003 126 10 2304 2311 (Pubitemid 37432373)
8. Sanders D. B., El-Salem K., Massey J. M., McConville J., Vincent A., Clinical aspects of MuSK antibody positive seronegative MG Neurology 2003 60 12 1978 1980 (Pubitemid 36736017)
9. Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., Tsujihata M., Vincent A., Eguchi K., Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis Annals of Neurology 2005 57 2 289 293 (Pubitemid 40179868)
10. Jha S., Xu K., Maruta T., Oshima M., Mosier D. R., Atassi M. Z., Hoch W., Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK) Journal of Neuroimmunology 2006 175 1-2 107 117 (Pubitemid 43765734)
11. Shigemoto K., Kubo S., Maruyama N., Hato N., Yamada H., Jie C., Kobayashi N., Mominoki K., Abe Y., Ueda N., Matsuda S., Induction of myasthenia by immunization against muscle-specific kinase Journal of Clinical Investigation 2006 116 4 1016 1024
12. Cole R. N., Reddel S. W., Gervsio O. L., Phillips W. D., Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction Annals of Neurology 2008 63 6 782 789 (Pubitemid 351945537)
13. Stroud R. M., Finer-Moore J., Acetylcholine receptor structure, function, and evolution Annual Review of Cell Biology 1985 1 317 351
14. Tzartos S. J., Lindstrom J. M., Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits Proceedings of the National Academy of Sciences of the United States of America 1980 77 2 755 759 (Pubitemid 10108379)
15. Tzartos S. J., Kokla A., Walgrave S. L., Conti-Tronconi B. M., Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 6776 of the subunit Proceedings of the National Academy of Sciences of the United States of America 1988 85 9 2899 2903
16. Asher O., Neumann D., Fuchs S., Increased levels of acetylcholine receptor -subunit mRNA in experimental autoimmune myasthenia gravis FEBS Letters 1988 233 2 277 281
17. Guyon T., Levasseur P., Truffault F., Cottin C., Gaud C., Berrih-Aknin S., Regulation of acetylcholine receptor subunit variants in human myasthenia gravis: quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction Journal of Clinical Investigation 1994 94 1 16 24
18. Sheng J. R., Li L. C., Prabhakar B. S., Meriggioli M. N., Acetylcholine receptor- subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis? Muscle and Nerve 2009 40 2 279 286
19. Castleman B., The pathology of the thymus gland in myasthenia gravis Annals of the New York Academy of Sciences 1966 135 1 496 503
20. Goldstein G., Myasthenia gravis and the thymus Annual Review of Medicine 1971 22 119 124
21. Ragheb S., Lisak R. P., Faber P. A. K. L. P., The thymus and myasthenia gravis Chest Surgery Clinics of North America: The Thymus 2001 Philadelphia, Pa, USA Saunders 311 327 (Pubitemid 32531715)
22. Hohlfeld R., Wekerle H., Reflections on the intrathymic pathogenesis of myasthenia gravis Journal of Neuroimmunology 2008 201-202 21 27
23. Le Panse R., Bismuth J., Cizeron-Clairac G., Weiss J. M., Cufi P., Dartevelle P., De Rosbo N. K., Berrih-Aknin S., Thymic remodeling associated with hyperplasia in myasthenia gravis Autoimmunity 2010 43 5-6 401 412
24. Farrar J., Portolano S., Willcox N., Vincent A., Jacobson L., Newsom-Davis J., Rapoport B., McLachlan S. M., Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library International Immunology 1997 9 9 1311 1318 (Pubitemid 27389013)
25. Graus Y. F., de Baets M. H., Parren P. W. H. I., Berrih-Aknin S., Wokke J., van Breda Vriesman P. J., Burton D. R., Human anti-nicotinic acetylcholine receptor recombinant fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies Journal of Immunology 1997 158 4 1919 1929 (Pubitemid 127469552)
26. Lindstrom J. M., Seybold M. E., Lennon V. A., Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value Neurology 1976 26 11 1054 1059
27. Scadding G. K., Vincent A., Newsom-Davis J., Henry K., Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology Neurology 1983 31 8 935 943 (Pubitemid 11061729)
28. Levinson A. I., Zweiman B., Lisak R. P., Dziarski A., Moskovitz A. R., Thymic B-cell activation in myasthenia gravis Neurology 1984 34 4 462 468 (Pubitemid 14127308)
29. Sims G. P., Shiono H., Willcox N., Stott D. I., Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis Journal of Immunology 2001 167 4 1935 1944 (Pubitemid 32747498)
30. Murai H., Hara H., Hatae T., Kobayashi T., Watanabe T., Expression of CD23 in the germinal center of thymus from myasthenia gravis patients Journal of Neuroimmunology 1997 76 1-2 61 69 (Pubitemid 27272629)
31. Liu Y. J., Cairns J. A., Holder M. J., Abbot S. D., Jansen K. U., Bonnefoy J. Y., Gordon J., MacLennan I. C. M., Recombinant 25-kDa CD23 and interleukin 1 promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis European Journal of Immunology 1991 21 5 1107 1114
32. Liu Y. J., Mason D. Y., Johnson G. D., Abbot S., Gregory C. D., Hardie D. L., Gordon J., MacLennan I. C. M., Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis European Journal of Immunology 1991 21 8 1905 1910
33. Cory S., Regulation of lymphocyte survival by the BCL-2 gene family Annual Review of Immunology 1995 13 513 543
34. Onodera J. I., Nakamura S., Nagano I., Tobita M., Yoshioka M., Takeda A., Oouchi M., Itoyama Y., Upregulation of Bcl-2 protein in the myasthenic thymus Annals of Neurology 1996 39 4 521 528 (Pubitemid 26118007)
35. Shiono H., Fujii Y., Okumura M., Takeuchi Y., Inoue M., Matsuda H., Failure to down-regulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis European Journal of Immunology 1997 27 4 805 809 (Pubitemid 27153645)
36. Gronseth G. S., Barohn R. J., Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2000 55 1 7 15 (Pubitemid 30460990)
37. Okumura M., Inoue M., Kadota Y., Hayashi A., Tokunaga T., Kusu T., Sawabata N., Shiono H., Biological implications of thymectomy for myasthenia gravis Surgery Today 2010 40 2 102 107
38. Vincent A., Scadding G. K., Thomas H. C., Newsom-Davis J., In vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis The Lancet 1978 1 8059 778 779
39. Levinson A. I., Dziarski A., Lisak R. P., Zweiman B., Brenner T., Abramsky O., Polyclonal B-cell activity in myasthenia gravis Neurology 1981 31 9 1198 1201 (Pubitemid 11019010)
40. Levinson A. I., Dziarski A., Lisak R. P., Zweiman B., Moskovitz A., Brenner T., Abramsky O., Comparative immunoglobulin synthesis by blood lymphocytes of myasthenics and normals Annals of the New York Academy of Sciences 1981 377 385 392
41. Lisak R. P., Laramore C., Zweiman B., Moskovitz A., In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood mononuclear cells of patients with myasthenia gravis Neurology 1983 33 5 604 608 (Pubitemid 13080449)
42. Scadding G. K., Vincent A., Newsom-Davis J., Henry K., Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology Neurology 1983 31 8 935 943 (Pubitemid 11061729)
43. Fujii Y., Monden Y., Hashimoto J., Nakahara K., Kawashima Y., Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis Clinical Immunology and Immunopathology 1985 34 1 141 146 (Pubitemid 15183913)
44. Lisak R. P., Levinson A. I., Zweiman B., Kornstein M. J., Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes Journal of Immunology 1986 137 4 1221 1225 (Pubitemid 16041106)
45. Levinson A. I., Zweiman B., Lisak R. P., Dziarski A., Moskovitz A. R., Thymic B-cell activation in myasthenia gravis Neurology 1984 34 4 462 468 (Pubitemid 14127308)
46. Link H., Olsson O., Sun J., Wang W. Z., Andersson G., Ekre H. P., Brenner T., Abramsky O., Olsson T., Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls Journal of Clinical Investigation 1991 87 6 2191 2196
47. Yi Q., Pirskanen R., Lefvert A. K., Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis Journal of Neuroimmunology 1993 42 2 215 222 (Pubitemid 23045893)
48. Moore P. A., Belvedere O., Orr A., Pieri K., LaFleur D. W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S. M., Olsen H. S., Fikes J., Hilbert D. M., BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 1999 285 5425 260 263 (Pubitemid 29330000)
49. Schneider P., Mackay F., Steiner V., Hofmann K., Bodmer J. L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R. H., Browning J. L., Tschopp J., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth Journal of Experimental Medicine 1999 189 11 1747 1756 (Pubitemid 29272691)
50. Nardelli B., Belvedere O., Roschke V., Moore P. A., Olsen H. S., Migone T. S., Sosnovtseva S., Carrell J. A., Feng P., Giri J. G., Hilbert D. M., Synthesis and release of B-lymphocyte stimulator from myeloid cells Blood 2001 97 1 198 204 (Pubitemid 32061261)
51. Craxton A., Magaletti D., Ryan E. J., Clark E. A., Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF Blood 2003 101 11 4464 4471 (Pubitemid 36857815)
52. Gorelik L., Gilbride K., Dobles M., Kalled S. L., Zandman D., Scott M. L., Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells Journal of Experimental Medicine 2003 198 6 937 945 (Pubitemid 37152930)
53. Scapini P., Nardelli B., Nadali G., Calzetti F., Pizzolo G., Montecucco C., Cassatella M. A., G-CSF-stimulated neutrophils are a prominent source of functional BLyS Journal of Experimental Medicine 2003 197 3 297 302 (Pubitemid 36184236)
54. Karpusas M., Cachero T. G., Qian F., Boriack-Sjodin A., Mullen C., Strauch K., Hsu Y. M., Kalled S. L., Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes Journal of Molecular Biology 2002 315 5 1145 1154 (Pubitemid 34729292)
55. Liu Y., Xu L., Opalka N., Kappler J., Shu H. B., Zhang G., Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands Cell 2002 108 3 383 394 (Pubitemid 34178402)
56. Oren D. A., Li Y., Volovik Y., Morris T. S., Dharia C., Das K., Galperina O., Gentz R., Arnold E., Structural basis of BLyS receptor recognition Nature Structural Biology 2002 9 4 288 292 (Pubitemid 34289902)
57. Mackay F., Woodcock S. A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations Journal of Experimental Medicine 1999 190 11 1697 1710 (Pubitemid 30002351)
58. Khare S. D., Sarosi I., Xia X. Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G., Ross L., Delaney J., Wang L., Lacey D., Boyle W. J., Hsu H., Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2000 97 7 3370 3375 (Pubitemid 30183309)
59. Gross J. A., Dillon S. R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K. P., Haugen H., McMillen S., Waggie K., Schreckhise R. W., Shoemaker K., Vu T., Moore M., Grossman A., Clegg C. H., TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS Immunity 2001 15 2 289 302 (Pubitemid 32816877)
60. Schiemann B., Gommerman J. L., Vora K., Cachero T. G., Shutga-Morskaya S., Dobles M., Frew E., Scott M. L., An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 2001 293 5537 2111 2114 (Pubitemid 32848063)
61. MacLennan I. C. M., Vinuesa C. G., Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses Immunity 2002 17 3 235 238 (Pubitemid 35279545)
62. Rolink A. G., Tschopp J., Schneider P., Melchers F., BAFF is a survival and maturation factor for mouse B cells European Journal of Immunology 2002 32 7 2004 2010 (Pubitemid 34814557)
63. Cancro M. P., Peripheral B-cell maturation: the intersection of selection and homeostasis Immunological Reviews 2004 197 89 101 (Pubitemid 38142170)
64. Jego G., Pascual V., Palucka A. K., Banchereau J., Dendritic cells control B cell growth and differentiation Current Directions in Autoimmunity 2005 8 124 139
65. MacKay F., Schneider P., Cracking the BAFF code Nature Reviews Immunology 2009 9 7 491 502
66. O'Connor B. P., Raman V. S., Erickson L. D., Cook W. J., Weaver L. K., Ahonen C., Lin L. L., Mantchev G. T., Bram R. J., Noelle R. J., BCMA is essential for the survival of long-lived bone marrow plasma cells Journal of Experimental Medicine 2004 199 1 91 98
67. Benson M. J., Dillon S. R., Castigli E., Geha R. S., Xu S., Lam K. P., Noelle R. J., Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL Journal of Immunology 2008 180 6 3655 3659
68. Do R. K. G., Hatada E., Lee H., Tourigny M. R., Hilbert D., Chen-Kiang S., Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response Journal of Experimental Medicine 2000 192 7 953 964
69. Hsu B. L., Harless S. M., Lindsley R. C., Hilbert D. M., Cancro M. P., Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators Journal of Immunology 2002 168 12 5993 5996 (Pubitemid 34620011)
70. Tardivel A., Tinel A., Lens S., Steiner Q. G., Sauberli E., Wilson A., Mackay F., Rolink A. G., Beermann F., Tschopp J., Schneider P., The anti-apoptotic factor Bcl-2 can functionally substitute for the cell survival but not for the marginal zone B cell differentiation activity of BAFF European Journal of Immunology 2004 34 2 509 518 (Pubitemid 39255961)
71. Craxton A., Draves K. E., Gruppi A., Clark E. A., BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway Journal of Experimental Medicine 2005 202 10 1363 1374 (Pubitemid 41668739)
72. Hartley S. B., Cooke M. P., Fulcher D. A., Harris A. W., Cory S., Basten A., Goodnow C. C., Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death Cell 1993 72 3 325 335 (Pubitemid 23059404)
73. Cyster J. G., Hartley S. B., Goodnow C. C., Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire Nature 1994 371 6496 389 395 (Pubitemid 24302553)
74. Lesley R., Xu Y., Kalled S. L., Hess D. M., Schwab S. R., Shu H. B., Cyster J. G., Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF Immunity 2004 20 4 441 453 (Pubitemid 38482122)
75. Thien M., Phan T. G., Gardam S., Amesbury M., Basten A., MacKay F., Brink R., Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches Immunity 2004 20 6 785 798 (Pubitemid 38757447)
76. Ota M., Duong B. H., Torkamani A., Doyle C. M., Gavin A. L., Ota T., Nemazee D., Regulation of the B cell receptor repertoire and self-reactivity by BAFF Journal of Immunology 2010 185 7 4128 4136
77. Smith S. H., Cancro M. P., Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors Journal of Immunology 2003 170 12 5820 5823 (Pubitemid 36682559)
78. Hase H., Kanno Y., Kojima M., Hasegawa K., Sakurai D., Kojima H., Tsuchiya N., Tokunaga K., Masawa N., Azuma M., Okumura K., Kobata T., BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex Blood 2004 103 6 2257 2265 (Pubitemid 38326245)
79. Noelle R. J., Erickson L. D., Determinations of B cell fate in immunity and autoimmunity Current Directions in Autoimmunity 2005 8 1 24
80. Stadanlick J. E., Cancro M. P., BAFF and the plasticity of peripheral B cell tolerance Current Opinion in Immunology 2008 20 2 158 161
81. Khan W. N., B cell receptor and BAFF receptor signaling regulation of B cell homeostasis Journal of Immunology 2009 183 6 3561 3567
82. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M. C., Ranchin B., Fabien N., Cochat P., Pouteil-Noble C., Trolliet P., Durieu I., Tebib J., Kassai B., Ansieau S., Puisieux A., Eliaou J. F., Bonnefoy-Bérard N., Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus Nature Immunology 2009 10 7 778 785
83. Sun M., Fink P. J., A new class of reverse signaling costimulators belongs to the TNF family Journal of Immunology 2007 179 7 4307 4312
84. Bossen C., Tardivel A., Willen L., Fletcher C. A., Perroud M., Beermann F., Rolink A. G., Scott M. L., Mackay F., Schneider P., Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses European Journal of Immunology 2011 41 3 787 797
85. Kim J. Y., Yang Y., Moon J. S., Lee E. Y., So S. H., Lee H. S., Park K. D., Choi Y. C., Serum BAFF expression in patients with myasthenia gravis Journal of Neuroimmunology 2008 199 1-2 151 154
86. Ragheb S., Lisak R., Lewis R., Van Stavern G., Gonzales F., Simon K., A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis Archives of Neurology 2008 65 10 1358 1362
87. Scuderi F., Alboini P. E., Bartoccioni E., Evoli A., BAFF serum levels in myasthenia gravis: effects of therapy. Journal of Neurology. In Press
88. Roses A. D., Olanow C. W., McAdams M. W., Lane R. J. M., No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis Neurology 1981 31 2 220 224 (Pubitemid 11137611)
89. Thangarajh M., Masterman T., Helgeland L., Rot U., Jonsson M. V., Eide G. E., Pirskanen R., Hillert J., Jonsson R., The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis Journal of Neuroimmunology 2006 178 1-2 161 166 (Pubitemid 44316862)
90. Gunn M. D., Ngo V. N., Ansel K. M., Ekland E. H., Cyster J. G., Williams L. T., A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 Nature 1998 391 6669 799 803 (Pubitemid 28099679)
91. Legler D. F., Loetscher M., Roos R. S., Clark-Lewis I., Baggiolini M., Moser B., B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 Journal of Experimental Medicine 1998 187 4 655 660 (Pubitemid 28093368)
92. Aloisi F., Pujol-Borrell R., Lymphoid neogenesis in chronic inflammatory diseases Nature Reviews Immunology 2006 6 3 205 217 (Pubitemid 43290990)
93. Badr G., Borhis G., Lefevre E. A., Chaoul N., Deshayes F., Dessirier V., Lapree G., Tsapis A., Richard Y., BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells Blood 2008 111 5 2744 2754
94. Meraouna A., Cizeron-Clairac G., Le Panse R., Bismuth J., Truffault F., Tallaksen C., Berrih-Aknin S., The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis Blood 2006 108 2 432 440 (Pubitemid 44061339)
95. Shiao Y. M., Lee C. C., Hsu Y. H., Huang S. F., Lin C. Y., Li L. H., Fann C. S. J., Tsai C. Y., Tsai S. F., Chiu H. C., Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia Journal of Neuroimmunology 2010 221 1-2 101 106
96. Santos M. A., Sarmento L. M., Rebelo M., Doce A. A., Maillard I., Dumortier A., Neves H., Radtke F., Pear W. S., Parreira L., Demengeot J., Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 39 15454 15459 (Pubitemid 47502938)
97. Thomas M., Calamito M., Srivastava B., Maillard I., Pear W. S., Allman D., Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation Blood 2007 109 8 3342 3350 (Pubitemid 46572522)
98. Yoon S. O., Zhang X., Berner P., Blom B., Choi Y. S., Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis Journal of Immunology 2009 183 1 352 358
99. Zhou L., Zhong R., Hao W., Wang H., Fan X., Zhang L., Mi Q., Interleukin-10 and interferon- up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells Experimental and Molecular Pathology 2009 87 1 54 58
100. Gandhi K. S., McKay F. C., Schibeci S. D., Arthur J. W., Heard R. N., Stewart G. J., Booth D. R., BAFF is a biological response marker to IFN- treatment in multiple sclerosis Journal of Interferon and Cytokine Research 2008 28 9 529 539
101. Krumbholz M., Faber H., Steinmeyer F., Hoffmann L. A., Kmpfel T., Pellkofer H., Derfuss T., Ionescu C., Starck M., Hafner C., Hohlfeld R., Meinl E., Interferon- increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity Brain 2008 131 6 1455 1463 (Pubitemid 351806460)
102. Xiao B. G., Duan R. S., Link H., Huang Y. M., Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells Cellular Immunology 2003 223 1 63 69 (Pubitemid 36945550)
103. Duan R. S., Adikari S. B., Huang Y. M., Link H., Xiao B. G., Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells Neurobiology of Disease 2004 16 2 461 467 (Pubitemid 38757326)
104. Scott B. G., Yang H., Tzn E., Dong C., Flavell R. A., Christadoss P., ICOS is essential for the development of experimental autoimmune myasthenia gravis Journal of Neuroimmunology 2004 153 1-2 16 25 (Pubitemid 38950923)
105. Balasa B., Deng C., Lee J., Bradley L. M., Dalton D. K., Christadoss P., Sarvetnick N., Interferon (IFN- ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice Journal of Experimental Medicine 1997 186 3 385 391 (Pubitemid 27332896)
106. Moiola L., Galbiati F., Martino G., Amadio S., Brambilla E., Comi G., Vincent A., Grimaldi L. M. E., Adorini L., IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease European Journal of Immunology 1998 28 8 2487 2497 (Pubitemid 28362723)
107. Sitaraman S., Metzger D. W., Belloto R. J. Jr., Infante A. J., Wall K. A., Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice Journal of Neuroimmunology 2000 107 1 73 82 (Pubitemid 30243133)
108. Poussin M. A., Goluszko E., Hughes T. K., Duchicella S. I., Christadoss P., Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR Journal of Neuroimmunology 2000 111 1-2 152 160
109. Zhang G. X., Xiao B. G., Yu L. Y., van der Meide P. H., Link H., Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR Journal of Neuroimmunology 2001 113 1 10 18 (Pubitemid 32008667)
110. Milani M., Ostlie N., Wang W., Conti-Fine B. M., T cells and cytokines in the pathogenesis of acquired myasthenia gravis Annals of the New York Academy of Sciences 2003 998 284 307 (Pubitemid 37194171)
111. Hanada T., Yoshida H., Kato S., Tanaka K., Masutani K., Tsukada J., Nomura Y., Mimata H., Kubo M., Yoshimura A., Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity Immunity 2003 19 3 437 450 (Pubitemid 37153419)
112. Heino M., Peterson P., Kudoh J., Nagamine K., Lagerstedt A., Ovod V., Ranki A., Rantala I., Nieminen M., Tuukkanen J., Scott H. S., Antonarakis S. E., Shimizu N., Krohn K., Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla Biochemical and Biophysical Research Communications 1999 257 3 821 825 (Pubitemid 29301524)
113. Kogawa K., Nagafuchi S., Katsuta H., Kudoh J., Tamiya S., Sakai Y., Shimizu N., Harada M., Expression of AIRE gene in peripheral monocyte/dendritic cell lineage Immunology Letters 2002 80 3 195 198 (Pubitemid 34136007)
114. Ramsey C., Hssler S., Marits P., Kmpe O., Surh C. D., Peltonen L., Winqvist O., Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator European Journal of Immunology 2006 36 2 305 317 (Pubitemid 43257453)
115. Hssler S., Ramsey C., Karlsson M. C., Larsson D., Herrmann B., Rozell B., Backheden M., Peltonen L., Kmpe O., Winqvist O., Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma Blood 2006 108 6 1941 1948 (Pubitemid 44395004)
116. Lindh E., Lind S. M., Lindmark E., Hssler S., Perheentupa J., Peltonen L., Winqvist O., Karlsson M. C. I., AIRE regulates T-cell-independent B-cell responses through BAFF Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18466 18471
117. Aricha R., Feferman T., Scott H. S., Souroujon M. C., Berrih-Aknin S., Fuchs S., The susceptibility of Aire -/- mice to experimental myasthenia gravis involves alterations in regulatory T cells Journal of Autoimmunity 2011 36 16 24
118. Kalled S. L., Ambrose C., Hsu Y. M., The biochemistry and biology of BAFF, APRIL and their receptors Current Directions in Autoimmunity 2005 8 206 242
119. von Blow G. U., Bram R. J., NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily Science 1997 278 5335 138 141 (Pubitemid 27446295)
120. Ng L. G., Sutherland A. P. R., Newton R., Qian F., Cachero T. G., Scott M. L., Thompson J. S., Wheway J., Chtanova T., Groom J., Sutton I. J., Xin C., Tangye S. G., Kalled S. L., Mackay F., Mackay C. R., B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells Journal of Immunology 2004 173 2 807 817 (Pubitemid 38924255)
121. Sasaki Y., Casola S., Kutok J. L., Rajewsky K., Schmidt-Supprian M., TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology Journal of Immunology 2004 173 4 2245 2252 (Pubitemid 39063079)
122. Shulga-Morskaya S., Dobles M., Walsh M. E., Ng L. G., MacKay F., Rao S. P., Kalled S. L., Scott M. L., B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation Journal of Immunology 2004 173 4 2331 2341 (Pubitemid 39063089)
123. Miller D. J., Hayes C. E., Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice European Journal of Immunology 1991 21 5 1123 1130
124. Harless S. M., Lentz V. M., Sah A. P., Hsu B. L., Clise-Dwyer K., Hilbert D. M., Hayes C. E., Cancro M. P., Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers Current Biology 2001 11 24 1986 1989 (Pubitemid 33146427)
125. Yan M., Brady J. R., Chan B., Lee W. P., Hsu B., Harless S., Cancro M., Grewal I. S., Dixit V. M., Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency Current Biology 2001 11 19 1547 1552 (Pubitemid 32931019)
126. Rahman Z. S. M., Rao S. P., Kalled S. L., Manser T., Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice Journal of Experimental Medicine 2003 198 8 1157 1169 (Pubitemid 37323381)
127. von Blow G. U., van Deursen J. M., Bram R. J., Regulation of the T-independent humoral response by TACI Immunity 2001 14 5 573 582 (Pubitemid 32520868)
128. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., Tumas D., Grewal I. S., Dixit V. M., Activation and accumulation of B cells in TACI-deficient mice Nature Immunology 2001 2 7 638 643 (Pubitemid 32677632)
129. Seshasayee D., Valdez P., Yan M., Dixit V. M., Tumas D., Grewal I. S., Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor Immunity 2003 18 2 279 288 (Pubitemid 36263002)
130. Sakurai D., Kanno Y., Hase H., Kojima H., Okumura K., Kobata T., TACI attenuates antibody production costimulated by BAFF-R and CD40 European Journal of Immunology 2007 37 1 110 118 (Pubitemid 46128791)
131. Castigli E., Wilson S. A., Garibyan L., Rachid R., Bonilla F., Schneider L., Geha R. S., TACI is mutant in common variable immunodeficiency and IgA deficiency Nature Genetics 2005 37 8 829 834 (Pubitemid 41077108)
132. Salzer U., Chapel H. M., Webster A. D. B., Pan-Hammarstrm Q., Schmitt-Graeff A., Schlesier M., Peter H. H., Rockstroh J. K., Schneider P., Schffer A. A., Hammarstrm L., Grimbacher B., Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans Nature Genetics 2005 37 8 820 828 (Pubitemid 41077107)
133. Poodt A. E. J., Driessen G. J. A., de Klein A., van Dongen J. J. M., van der Burg M., de Vries E., TACI mutations and disease susceptibility in patients with common variable immunodeficiency Clinical and Experimental Immunology 2009 156 1 35 39
134. Xu S., Lam K. P., B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses Molecular and Cellular Biology 2001 21 12 4067 4074 (Pubitemid 32476467)
135. Avery D. T., Kalled S. L., Ellyard J. I., Ambrose C., Bixler S. A., Thien M., Brink R., MacKay F., Hodgkin P. D., Tangye S. G., BAFF selectively enhances the survival of plasmablasts generated from human memory B cells Journal of Clinical Investigation 2003 112 2 286 297 (Pubitemid 38056364)
136. Zhang X., Park C. S., Yoon S. O., Li L., Hsu Y. M., Ambrose C., Choi Y. S., BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors International Immunology 2005 17 6 779 788 (Pubitemid 41417976)
137. Darce J. R., Arendt B. K., Wu X., Jelinek D. F., Regulated expression of BAFF-binding receptors during human B cell differentiation Journal of Immunology 2007 179 11 7276 7286
138. Bossen C., Schneider P., BAFF, APRIL and their receptors: structure, function and signaling Seminars in Immunology 2006 18 5 263 275 (Pubitemid 44287558)
139. Brink R., Regulation of B cell self-tolerance by BAFF Seminars in Immunology 2006 18 276 283 (Pubitemid 44287554)
140. Kalled S. L., Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production Seminars in Immunology 2006 18 5 290 296 (Pubitemid 44382641)
141. Li X., Xiao B. G., Xi J. Y., Lu C. Z., Lu J. H., Decrease of CD4 + CD 25 high Foxp3 + regulatory T cells and elevation of CD19 + BAFF-R + B cells and soluble ICAM-1 in myasthenia gravis Clinical Immunology 2008 126 2 180 188
142. Thangarajh M., Kisiswa L., Pirskanen R., Hillert J., The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis Scandinavian Journal of Immunology 2007 65 5 461 466 (Pubitemid 46632544)
143. Bonizzi G., Karin M., The two NF- B activation pathways and their role in innate and adaptive immunity Trends in Immunology 2004 25 6 280 288 (Pubitemid 38610351)
144. Claudio E., Brown K., Park S., Wang H., Siebenlist U., BAFF-induced NEMO-independent processing of NF- B2 in maturing B cells Nature Immunology 2002 3 10 958 965 (Pubitemid 35154010)
145. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D. M., Grewal I. S., Cochran A. G., Gordon N. C., Yin J., Starovasnik M. A., Dixit V. M., BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF- B2 Immunity 2002 17 4 515 524 (Pubitemid 35223539)
146. Enzler T., Bonizzi G., Silverman G., Otero D. C., Widhopf G., Anzelon-Mills A., Rickert R., Karin M., Alternative and classical NF- B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease Immunity 2006 25 3 403 415 (Pubitemid 44354213)
147. Sasaki Y., Derudder E., Hobeika E., Pelanda R., Reth M., Rajewsky K., Schmidt-Supprian M., Canonical NF- B activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation Immunity 2006 24 6 729 739 (Pubitemid 43867365)
148. Liao G., Zhang M., Harhaj E. W., Sun S. C., Regulation of the NF- B-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation Journal of Biological Chemistry 2004 279 25 26243 26250 (Pubitemid 38798772)
149. Morrison M. D., Reiley W., Zhang M., Sun S. C., An atypical Tumor Necrosis Factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF- B signaling pathway Journal of Biological Chemistry 2005 280 11 10018 10024 (Pubitemid 40395852)
150. Xie P., Stunz L. L., Larison K. D., Yang B., Bishop G. A., Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs Immunity 2007 27 2 253 267 (Pubitemid 47284931)
151. Gardam S., Sierro F., Basten A., Mackay F., Brink R., TRAF2 and TRAF3 Signal Adapters Act Cooperatively to Control the Maturation and Survival Signals Delivered to B Cells by the BAFF Receptor Immunity 2008 28 3 391 401
152. Vallabhapurapu S., Matsuzawa A., Zhang W. Z., Tseng P. H., Keats J. J., Wang H., Vignali D. A. A., Bergsagel P. L., Karin M., Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF- B signaling Nature Immunology 2008 9 12 1364 1370
153. Chan T. D., Gardam S., Gatto D., Turner V. M., Silke J., Brink R., in vivo control of B-cell survival and antigen-specific B-cell responses Immunological Reviews 2010 237 1 90 103
154. Huard B., Arlettaz L., Ambrose C., Kindler V., Mauri D., Roosnek E., Tschopp J., Schneider P., French L. E., BAFF production by antigen-presenting cells provides T cell co-stimulation International Immunology 2004 16 3 467 475 (Pubitemid 38313155)
155. Sutherland A. P. R., Ng L. G., Fletcher C. A., Shum B., Newton R. A., Grey S. T., Rolph M. S., Mackay F., Mackay C. R., BAFF augments certain Th1-associated inflammatory responses Journal of Immunology 2005 174 9 5537 5544 (Pubitemid 40593194)
156. Lam Q. L. K., Ko O. K. H., Zheng B. J., Lu L., Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 14993 14998
157. Tangye S. G., Bryant V. L., Cuss A. K., Good K. L., BAFF, APRIL and human B cell disorders Seminars in Immunology 2006 18 5 305 317 (Pubitemid 44287555)
158. Baker K. P., Edwards B. M., Main S. H., Choi G. H., Wager R. E., Halpern W. G., Lappin P. B., Riccobene T., Abramian D., Sekut L., Sturm B., Poortman C., Minter R. R., Dobson C. L., Williams E., Carmen S., Smith R., Roschke V., Hilbert D. M., Vaughan T. J., Albert V. R., Generation and characterization of lymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator Arthritis Rheumatism 2003 48 11 3253 3265 (Pubitemid 37409340)
159. Lin W. Y., Gong Q., Seshasayee D., Lin Z., Ou Q., Ye S., Suto E., Shu J., Wyne P. L., Lee C. W. V., Fuh G., Leabman M., Iyer S., Howell K., Gelzleichter T., Beyer J., Danilenko D., Yeh S., DeForge L. E., Ebens A., Thompson J. S., Ambrose C., Balazs M., Starovasnik M. A., Martin F., Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade Blood 2007 110 12 3959 3967 (Pubitemid 350248451)
160. Vugmeyster Y., Seshasayee D., Chang W., Storn A., Howell K., Sa S., Nelson T., Martin F., Grewal I., Gilkerson E., Wu B., Thompson J., Ehrenfels B. N., Ren S., Song A., Gelzleichter T. R., Danilenko D. M., A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys The American Journal of Pathology 2006 168 2 476 489 (Pubitemid 43271146)
161. Carbonatto M., Yu P., Bertolino M., Vigna E., Steidler S., Fava L., Daghero C., Roattino B., Onidi M., Ardizzone M., Peano S., Visich J., Janszen D., Dillon S., Ponce R., Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept Toxicological Sciences 2008 105 1 200 210
162. Espinosa G., Cervera R., Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus Drugs of Today 2010 46 12 891 899
163. Stohl W., Scholz J. L., Cancro M. P., Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside Current Opinion in Rheumatology 2011 23 3 305 310
164. Dall'Era M., Chakravarty E., Wallace D., Genovese M., Weisman M., Kavanaugh A., Kalunian K., Dhar P., Vincent E., Pena-Rossi C., Wofsy D., Alum N., Dubois A., Kinnman N., Picard M., Bortolotti A., O'Grady L., Hill J., Nestorov I., Salmon E., Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial Arthritis Rheumatism 2007 56 12 4142 4150 (Pubitemid 350262342)
165. Tak P. P., Thurlings R. M., Rossier C., Nestorov I., Dimic A., Mircetic V., Rischmueller M., Nasonov E., Shmidt E., Emery P., Munafo A., Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study Arthritis Rheumatism 2008 58 1 61 72
166. Stewart D. M., McAvoy M. J., Hilbert D. M., Nelson D. L., B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro Clinical Immunology 2003 109 2 137 143 (Pubitemid 37338620)
167. Chen L., Ran M. J., Shan X. X., Cao M., Cao P., Yang X. M., Zhang S. Q., BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens Vaccine 2009 27 9 1393 1399
168. Tertilt C., Joh J., Krause A., Chou P., Schneeweiss K., Crystal R. G., Worgall S., Expression of B-cell activating factor enhances protective immunity of a vaccine against pseudomonas aeruginosa Infection and Immunity 2009 77 7 3044 3055
169. Zen M., Canova M., Campana C., Bettio S., Nalotto L., Rampudda M., Ramonda R., Iaccarino L., Doria A., The kaleidoscope of glucorticoid effects on immune system Autoimmunity Reviews 2011 10 6 305 310
170. Le Pottier L., Bendaoud B., Dueymes M., Daridon C., Youinou P., Shoenfeld Y., Pers J. O., BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer Journal of Clinical Immunology 2007 27 3 257 265 (Pubitemid 46790821)